Gritstone Oncology Company
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Investors
.png)
.png)
.png)
Technology:
Biotechnology, Health Care, Therapeutics
Industry:
Tumor-Specific Antigens
Headquarters:
Emeryville, California, United States
Founded Date:
2015-08-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
16
Total Funding:
396000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-09-16
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership